2016 Aug 15
Are we ready for precision medicine in acute myeloid leukemia?
Gail J. Roboz, M.D., discusses the genetics of AML and emerging treatments. Read more
2016 Aug 10
Pancreatic cancer cells find unique fuel sources to keep from starving
Meyer director Lewis Cantley and former postdoc Costas Lyssiotis were involved in a study about pancreatic cancer metabolism. Read more
2016 Aug 09
Elemento Lab helps identify new class of cancer drugs
Working with Oncoceutics, the lab of Olivier Elemento, Ph.D, helped identify a drug that has demonstrated excellent anti-cancer activity and has led to the creation of a new family of chemically-related small molecules. Read more
2016 Aug 09
The Role of PARP Inhibitors in Prostate Cancer
Christopher E. Barbieri, M.D., Ph.D., discusses the role of PARP inhibitors in castration-resistant prostate cancer. Read more
2016 Aug 05
Emerging approaches in MDS treatment
Ellen Ritchie, M.D., took part in a video series about Myelodysplastic Syndromes: Translating Genetics to Clinics Read more
2016 Aug 05
New PTEN role identified in mitosis
Wen Shen, Ph.D., has identified a critical function of the protein PTEN to protect the process by which cells divide, a finding that could help lead to therapies that prevent tumor growth. Read more
2016 Aug 04
Seeking out the sweet spot in cancer therapeutics
Meyer director Lewis Cantley, Ph.D., discusses life in and out of the lab. Read more
2016 Aug 04
21 completely reassuring things scientists wish you knew about cancer
Meyer director Lewis Cantley, Ph.D., shares some of his advice for those facing cancer, or looking to prevent it. Read more
2016 Aug 02
From ‘tache to test: Movember Foundation funds research into non-invasive blood test for metastatic prostate cancer
Himisha Beltran, M.D., and colleagues are developing a blood test to detect and track circulating tumor DNA of metastatic prostate cancer. Read more
2016 Aug 01
Sift, Sort, Seize Transcriptomic Gold
Olivier Elemento, Ph.D., discusses computational methods his lab has developed to target oncogenic transcription factors. Read more
2016 Jul 27
We Are Weill Cornell Medicine : Dr. Silvia Formenti
Video profile of radiation oncologist Silvia Formenti, M.D. Read more
2016 Jul 26
Distinguished panel discusses role of creativity in science
Harold Varmus, M.D., participated in a panel discussion at Cornell University in Ithaca about the role of creativity in science. Read more
2016 Jul 21
How to be healthy at every age
Anne Moore, M.D., shares some advice about health for women in their 40s. Read more
2016 Jul 21
A pancreatic cancer community that crowdsources new treatments
Allyson Ocean, M.D., has teamed up with a patient to create an online pancreatic cancer resource. Read more
2016 Jul 20
Early treatment delays time to progression in some asymptomatic myeloma patients
Ruben Niesvizky, M.D., comments on a potentially "paradigm-shifting" approach to treating smoldering multiple myeloma. Read more
2016 Jul 20
Weill Cornell Medicine to expand tumor exome test to thousands of advanced cancer patients
The EXact-1 precision cancer test has been validated for clinical usage, and the Englander Institute is already working on EXact-2. Read more
2016 Jul 20
The ‘Quantum Theory’ of cancer treatment
Silvia Formenti, M.D., and Sandra Demaria, M.D., describe the "abscopal effect." Read more
2016 Jul 19
Metabolic protein linked to cancer and autoimmunity
Scientists in the lab of Meyer director Lewis Cantley, Ph.D., have found that the gene PIP4K2C and its associated protein PI5P4Kγ play a role in the regulation of the immune system. Read more
2016 Jul 18
Pathway to collaboration
Karen Vousden, director of the Cancer Research UK Beatson Institute in Glasgow, Scotland, recently spent a month at the Meyer Cancer Center as part of the Vallee Visiting Professorship program. Read more
2016 Jul 16
Novel testing approaches better equip physicians to identify myeloma risks
Adriana Rossi, M.D., discusses how physicians are becoming better equipped to detect monoclonal gammopathy of undetermined significance, which may help identify patients at risk for myeloma. Read more
